Transforming Growth Factor-β Induces Expression of Receptor Activator of NF-κB Ligand in Vascular Endothelial Cells Derived from Bone
Open Access
- 1 July 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (29), 26217-26224
- https://doi.org/10.1074/jbc.m111093200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)Journal of Biological Chemistry, 2000
- Bone Morphogenetic Protein-2 Enhances Osteoclast Formation Mediated by Interleukin-1α through Upregulation of Osteoclast Differentiation Factor and Cyclooxygenase-2Biochemical and Biophysical Research Communications, 1999
- Basic Fibroblast Growth Factor Induces Cyclooxygenase-2 Expression in Endothelial Cells Derived from BoneBiochemical and Biophysical Research Communications, 1999
- Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like CellsBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Transforming Growth Factor-β1 Stimulates Protein Kinase A in Mesangial CellsPublished by Elsevier BV ,1998
- Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.JCI Insight, 1995
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- An investigation of vanishing bone diseaseBone, 1990
- Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133Cell, 1989